- Home
- CERO vs AUUD Comparison
CERO vs AUUD Comparison
Compare CERO & AUUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERO
- AUUD
- Stock Information
- Founded
- CERO 2017
- AUUD 2012
- Country
- CERO United States
- AUUD United States
- Employees
- CERO N/A
- AUUD N/A
- Industry
- CERO
- AUUD Computer Software: Prepackaged Software
- Sector
- CERO
- AUUD Technology
- Exchange
- CERO Nasdaq
- AUUD Nasdaq
- Market Cap
- CERO 3.5M
- AUUD 2.9M
- IPO Year
- CERO N/A
- AUUD 2021
- Fundamental
- Price
- CERO $9.93
- AUUD $6.12
- Analyst Decision
- CERO Strong Buy
- AUUD
- Analyst Count
- CERO 2
- AUUD 0
- Target Price
- CERO $45.00
- AUUD N/A
- AVG Volume (30 Days)
- CERO 3.3M
- AUUD 66.5K
- Earning Date
- CERO 08-13-2025
- AUUD 08-06-2025
- Dividend Yield
- CERO N/A
- AUUD N/A
- EPS Growth
- CERO N/A
- AUUD N/A
- EPS
- CERO N/A
- AUUD N/A
- Revenue
- CERO N/A
- AUUD N/A
- Revenue This Year
- CERO N/A
- AUUD N/A
- Revenue Next Year
- CERO N/A
- AUUD N/A
- P/E Ratio
- CERO N/A
- AUUD N/A
- Revenue Growth
- CERO N/A
- AUUD N/A
- 52 Week Low
- CERO $6.71
- AUUD $2.88
- 52 Week High
- CERO $895.40
- AUUD $31.62
- Technical
- Relative Strength Index (RSI)
- CERO 50.09
- AUUD 49.64
- Support Level
- CERO $8.12
- AUUD $4.11
- Resistance Level
- CERO $13.14
- AUUD $4.54
- Average True Range (ATR)
- CERO 2.83
- AUUD 0.41
- MACD
- CERO 0.39
- AUUD -0.08
- Stochastic Oscillator
- CERO 19.58
- AUUD 30.77
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.